Introduction
The National Drug Code (NDC) 49884-161-11 corresponds to Calcitonin Salmon Nasal Solution, a medication used for the treatment of postmenopausal osteoporosis. This article provides a comprehensive market analysis and price projections for this drug, considering various factors such as regulatory requirements, market trends, and global price comparisons.
Regulatory Overview
The NDC 49884-161-11 is listed in the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs submitted by labelers. The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size[1][5].
Market Context
Drug Classification and Usage
Calcitonin Salmon Nasal Solution is classified as a human prescription drug, indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause. It is marketed by Par Pharmaceutical, Inc.[3].
Global Price Comparisons
Studies have shown that prescription drug prices in the United States are significantly higher than in many other countries. For instance, U.S. prices for brand-name originator drugs are 344% of those in comparison OECD countries, while prices for unbranded generic drugs are generally lower in the U.S. compared to other countries[2].
Market Trends
Pharmacy Market Outlook
The Vizient Pharmacy Market Outlook for 2024-2025 projects a stable overall drug price inflation rate of 0.00% for the period between January 1, 2025, and December 31, 2025. However, this outlook does not specifically address the prices of individual drugs like Calcitonin Salmon Nasal Solution[4].
Gene Therapy and Advanced Treatments
While the focus on gene therapy and other advanced treatments highlights the escalating costs of healthcare, it does not directly impact the pricing of established drugs like Calcitonin Salmon Nasal Solution. However, it underscores the broader trend of increasing healthcare costs and the need for sustainable financial models[4].
Price Projections
Current Pricing
As of the latest data, specific price projections for Calcitonin Salmon Nasal Solution (NDC 49884-161-11) are not readily available. However, given the general trend of stable or slightly increasing prices for prescription drugs, it is reasonable to expect that the price of this drug will remain relatively stable or increase marginally.
Comparative Pricing
In the context of global price comparisons, if Calcitonin Salmon Nasal Solution were to follow the trend of brand-name originator drugs, its price in the U.S. would likely remain significantly higher than in other OECD countries. However, since it is not a newly approved drug, its pricing is less likely to be as volatile as that of newer, more expensive therapies[2].
Factors Influencing Pricing
Regulatory Compliance
Drug establishments must update their drug listing data in June and December of each year to ensure compliance with FDA regulations. Any changes in the listing status or compliance issues could potentially affect the availability and pricing of the drug[1].
Market Demand and Competition
The demand for osteoporosis treatments and the presence of competing drugs can influence the pricing strategy. If there are alternative treatments gaining market share, the price of Calcitonin Salmon Nasal Solution might be adjusted to remain competitive.
Economic and Policy Factors
Economic conditions, healthcare policies, and reimbursement rates can also impact drug pricing. For example, changes in Medicare or Medicaid reimbursement policies could affect the market price of prescription drugs, including Calcitonin Salmon Nasal Solution.
Conclusion
The market analysis and price projections for Calcitonin Salmon Nasal Solution (NDC 49884-161-11) suggest a relatively stable pricing environment, influenced by broader trends in prescription drug pricing. While specific price projections are not available, the drug is likely to maintain its current pricing structure, with potential minor adjustments based on market demand, competition, and regulatory compliance.
Key Takeaways
- Regulatory Compliance: The drug must comply with FDA regulations, including regular updates to the NDC Directory.
- Global Price Comparisons: U.S. prices for brand-name drugs are generally higher than in other OECD countries.
- Market Trends: Stable overall drug price inflation is projected for 2025, but specific drug prices can vary.
- Pricing Factors: Market demand, competition, and economic policies can influence drug pricing.
- Healthcare Costs: The broader trend of increasing healthcare costs underscores the need for sustainable financial models.
FAQs
Q: What is the NDC code for Calcitonin Salmon Nasal Solution?
A: The NDC code for Calcitonin Salmon Nasal Solution is 49884-161-11.
Q: What is the primary use of Calcitonin Salmon Nasal Solution?
A: Calcitonin Salmon Nasal Solution is used for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause.
Q: How do U.S. prices for prescription drugs compare to those in other countries?
A: U.S. prices for brand-name originator drugs are significantly higher than in many other OECD countries, while prices for unbranded generic drugs are generally lower in the U.S.[2].
Q: What are the key factors influencing the pricing of Calcitonin Salmon Nasal Solution?
A: Key factors include regulatory compliance, market demand, competition, and economic policies.
Q: Are there any specific price projections available for Calcitonin Salmon Nasal Solution for 2025?
A: As of the latest data, specific price projections for this drug are not readily available, but it is expected to remain relatively stable or increase marginally.
Sources
- FDA: National Drug Code Database Background Information.
- ASPE: International Prescription Drug Price Comparisons.
- DailyMed: Calcitonin Salmon spray, metered.
- Vizient Inc.: Pharmacy Market Outlook Summer 2024.
- FDA: National Drug Code Directory.